A Novel Urinary Access System for Universal Transcatheter Cystoscopy at The Time of Hysterectomy
A Novel Urinary Access System for Universal Transcatheter Cystoscopy at The Time of Hysterectomy
Cystoscopy is a commonly performed procedure after gynecologic surgery, however, its use may
 increase patients' risk for acquiring urinary tract infections due to urinary tract
 instrumentation entry and reentry of the lower urinary tract with the cystoscope and foley
 catheter. Use of a novel multi-channel transurethral bladder catheter that allows for
 cystoscopy through a specialized port will permit cystoscopy to be performed without catheter
 removal. This may allow for intraoperative detection of urinary tract injuries with a
 reduction in both urethral manipulation and hospital-associated urinary tract infections.
 Other potential benefits may include a shorter procedure time and ease of use for providers.
A cystoscopy is a procedure that inserts a thin tube with a light and camera through the
 urethra, so that the inside of the bladder can be checked for injuries. Current guidelines
 recommend that this is done after a hysterectomy. Normally, doing a cystoscopy requires that
 a patient's foley catheter (a tube inserted through the urethra and into the bladder to drain
 urine) gets removed and then replaced. This can potentially lead to a urinary tract infection
 (UTI).

 CystoSureTM is a silicone device that was developed by surgeons to enable easy and
 standardized cystoscopy. The design of the CystoSureTM catheter has separate channels for
 draining the bladder and performing cystoscopy, so doctors can perform a cystoscopy without
 removing the catheter (which can, as described above, potentially lead to a UTI). In this
 study, investigators want to examine whether using a CystoSureTM catheter instead of a
 standard foley catheter could therefore lead to a reduced number of UTIs in hysterectomy
 patients. CystoSureTM is cleared by the FDA.
Inclusion Criteria:

 -  Women age 18-90

 -  Undergoing hysterectomy with or without concomitant procedures

 Exclusion Criteria:

 -  Known history of urinary tract anomaly (i.e. urethral diverticulum, ureteral
 duplication, ectopic ureter)

 -  ≥3 UTIs in past 6 months

 -  Immunosuppressed patients

 -  Premeditated urologic procedure during hysterectomy surgery